Nominations are due this Friday for M&A's 17th Annual Deals of the Year Awards. Click here to learn more!

HMO drug candidates

Intrinsic Merges with PBAX

The resources of the combined company look to provide Intrinsic with the capital to advance OM002, a synthetic biology-produced HMO drug candidate.
October 31, 2022